|

iExposure Intervention for Social Anxiety

RECRUITINGN/ASponsored by Palo Alto University
Actively Recruiting
PhaseN/A
SponsorPalo Alto University
Started2024-07-01
Est. completion2026-06-30
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site

Summary

Social anxiety (SA) is a highly prevalent mental health concern, thought to disproportionately affect youth with recent international estimates of more than 30% of individuals reporting clinically elevated symptoms. Despite the prevalence of SA, as few as one in five individuals receive care, due to limited access to evidence-based treatments. Additionally there has been a notable increase in social anxiety since the start of the COVID-19 pandemic. This proposal will use iExposure to develop a personalized mechanism-focused approach to optimizing treatment response for individuals with social anxiety by testing standard iExposure against two augmentations that incorporate distinct attention mechanisms (attention guidance and attention control).

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Age 18 or older
* Fluent in English
* Leibowitz Social Anxiety Scale \> 47 and endorses both social anxiety items on the Web Screening Questionnaire for Common Mental Disorders

Exclusion Criteria:

* Currently receiving CBT for Social Anxiety Disorder
* Significant visual impairment precluding engagement in the simulated teleconferencing interactions
* Unstable dose of psychotropic medications within 6 weeks prior to baseline assessment
* Current alcohol or substance use disorder
* Current or past bipolar disorder or psychosis

Conditions2

AnxietySocial Anxiety

Locations1 site

Palo Alto University
Palo Alto, California, 94304
Mikael Rubin, PhD650-433-3805mrubin@paloaltou.edu

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.